Virtonomy accelerates medical device development using digital patient twins and simulations. Its v-Patients enable virtual testing, reducing risks, costs, and regulatory burden, powered by diverse, real clinical data for accuracy.
Founded in 2019, Virtonomy is a healthtech company focused on accelerating the time-to-market of medical products by conducting data-driven studies on virtual patients. Its solution is built on an ever-expanding database designed to reflect anatomical variability, demographic diversity, and a wide range of pathological conditions, enabling more accurate and representative simulations. Virtonomy supports medical device manufacturers across all stages of the product lifecycle from concept development and pre-clinical evaluation to post-market surveillance—helping them better understand target anatomy, optimize device fit for broader patient populations, identify suitable in-vivo models, and enhance clinical trials through precise sub-population selection. Headquartered in Munich, Germany, the company brings together an interdisciplinary team of experts in medical engineering, data and image processing, visualization, and clinical practice, delivering innovative solutions that improve efficiency, reduce risk, and advance the development of medical technologies.